I Want To
Our Expertise
- Commercialization Models
  - Launch a ProductCOMPLETE Commercialization is an integrated commercialization model aligning strategy, access, marketing, and supply to launch products faster with confidence.
  - Direct-to-PatientTransform access with a patient‑focused model that streamlines care, improves adherence and reduces barriers to treatment.
  - In-Line AssetsRevitalize established brands with targeted strategies to reignite revenue, strengthen performance and extend their value.
  - Oncology CommercializationOptimize oncology launches with expert support, a ready‑to‑deploy engine and reduced launch risk.
- AI Accelerator
  - AI AcceleratorCenter of Excellence to speed AI adoption and built AI accelerators for Life Sciences.
  - AI Agency PlatformProven AI platform, in partnership with Google, where you control data, outputs, and commercial roadmap.
  - Orchestrate Operating SystemAn operating system unifying data, workflows, and execution across EVERSANA’s integrated ecosystem.
- Global Commercialization
  - European CommercializationAccelerate European commercialization with integrated launch, market access, engagement, and sustained growth services across markets.
  - Asia Pacific CommercializationAccelerate Asia Pacific commercialization with integrated launch, market access, engagement, and scalable growth across diverse and rapidly evolving markets.
- Therapeutic Depth
  - OncologyHarness deep oncology expertise and integrated support to accelerate development, launch and patient impact.
  - RareAdvance rare‑disease care with expert guidance, innovative technology and integrated support to speed patient access.
  - Cell & GeneLead cell & gene therapy success with a patient‑centered approach across the full lifecycle.
  - Neurology & CNSEnhance neurology and CNS therapies with specialized experience and connected services for complex patient needs.
  - Digital MedicinesEnable digital health innovation with services that personalize support, improve outcomes and meet value‑based care demands.
Our Services
- Distribution & Channel Management
  - Global Channel Management & 3PLOptimize global distribution with lean, tech‑driven 3PL solutions enabling fast, accurate and compliant delivery.
  - e-CommerceEnable direct‑to‑provider sales with a flexible e‑commerce model offering direct access, real‑time visibility and operational efficiency.
- Field Deployment
  - Field Deployment SolutionsStrengthen commercial impact with strategic solutions that drive access, affordability and targeted stakeholder engagement.
  - Medical DeploymentSupport product success with agile medical teams improving scientific conversations and maximizing strategic impact.
  - Learning & Performance ServicesEmpower teams with tailored learning solutions combining clinical insight, market access knowledge and selling skills.
- Patient Services
  - Access & HubEmpower patients with streamlined access solutions that simplify onboarding and accelerate the path to therapy.
  - Adherence SolutionsImprove adherence with tailored solutions that blend advanced technology, education and human support.
  - Affordability, Co-Pay & PAPStrengthen access through affordability programs designed to ease financial burdens and streamline coverage pathways.
  - Specialty PharmacyDeliver integrated clinical support, seamless access, coordinated care and precise delivery for complex therapies.
  - In-Home Nursing & Clinical SupportProvide safe, coordinated in‑home clinical care that supports ongoing treatment and complex therapies.
  - Clinical Trial ProgramsElevate trial performance through connected solutions that improve access, simplify participation and support retention.
- Market Access & Value
  - Market Access StrategiesPower your brand with integrated strategies built to define value, guide pricing and strengthen coverage.
  - Market Shaping Activation ModelDevelop market need for the therapy and build brand awareness across stakeholders.
  - Market Access & ReimbursementBreak down the complexity and navigate today’s shifts in healthcare.
  - Pricing & Revenue ManagementOptimize your revenue with solutions that improve pricing accuracy, reduce leakage and support regulatory compliance.
  - HEOR, Value & EvidenceStrengthen product value with evidence‑based insights and real‑world data that guide strategy and support decisions.
- Marketing
  - Patient, Payer & Provider MarketingDrive breakthrough results with insight‑led marketing powered by creativity, advanced tech and global expertise.
  - Digital Transformation & InnovationFuture‑proof your brand with AI‑enabled innovation and advanced tech solutions built for smarter execution.
- Medical Affairs
  - Medical Affairs StrategyAdvance decision‑making with evidence‑led expertise focused on improving care pathways and health outcomes.
  - Commercial ComplianceTransform compliance into a strategic advantage with integrated solutions that enhance quality and safety.
  - Medical InformationSupport launches and global growth with integrated, scalable solutions designed for evolving healthcare needs.
  - PharmacovigilanceLeverage GenAI and real‑time insights to elevate safety performance and enable faster, informed decisions.
  - Quality Assurance / Quality Management SystemsEnsure compliance and reduce risk with lifecycle‑wide quality solutions built for global readiness.
  - Regulatory Medical AffairsStrengthen product success with tailored strategies that support global clearance and guide development milestones.
- Strategy & Consulting
  - Management ConsultingNavigate healthcare complexity with expert insights, analytics and strategy that drive sustainable growth.
  - Regulatory ConsultingProvide customized solutions that accelerates approvals and supports every stage of development.
Our Products
- AI Enabled Marketing
  - OmnichannelUnify data, services, and activation into a single omnichannel model purpose-built for life sciences commercialization.
  - AI Agency PlatformProven AI platform, in partnership with Google, where you control data, outputs, and commercial roadmap.
  - Medical & Legal ReviewsStreamline medical and legal reviews with compliant, faster workflows purpose-built for life sciences teams globally.
- Compliance Operations
  - Literature Monitoring & Aggregate AuthoringLeverage integrated literature monitoring and aggregate authoring powered by connected data and scientific services.
  - Donor Eligibility SystemEnsure compliant donor eligibility with an integrated software that combines data, workflows, and life sciences expertise.
- Pricing & Market Access Products
  - Price & Access DataActivate NAVLIN price and access data through an integrated platform connecting insights, analytics, and decisions.
  - Research & InsightsMake smarter portfolio decisions with real-time visibility. The only digital platform and policy tracker that unifies all your market access insights.
  - Price & Access SoftwareDrive successful pricing governance decisions across global markets.
  - Revenue ManagementIntegrate your gross-to-net into the commercialization ecosystem.
- Data & Analytics
  - Commercial AnalyticsOptimize commercial performance with integrated analytics connecting data, insights, and activation.
  - Integrated Patient AnalyticsUnify patient data to reveal insights, personalize engagement, and improve outcomes.
  - Commercial Intelligence 360Unified intelligence platform designed to bring clarity, speed, and scalability to commercialization.
  - Patient Relationship AccessBuild trusted patient relationships by integrating access, engagement, and support across the ecosystem.
  - ACTICS eAccessState-of-the-art simplified benefits verification to accelerate reimbursement and access.
  - RWE & HEORDeliver robust real-world evidence and insights that demonstrate value, strengthen access, and inform decisions.
Our Insights

I Want To
Our Expertise
- Commercialization Models
  - Launch a ProductCOMPLETE Commercialization is an integrated commercialization model aligning strategy, access, marketing, and supply to launch products faster with confidence.
  - Direct-to-PatientTransform access with a patient‑focused model that streamlines care, improves adherence and reduces barriers to treatment.
  - In-Line AssetsRevitalize established brands with targeted strategies to reignite revenue, strengthen performance and extend their value.
  - Oncology CommercializationOptimize oncology launches with expert support, a ready‑to‑deploy engine and reduced launch risk.
- AI Accelerator
  - AI AcceleratorCenter of Excellence to speed AI adoption and built AI accelerators for Life Sciences.
  - AI Agency PlatformProven AI platform, in partnership with Google, where you control data, outputs, and commercial roadmap.
  - Orchestrate Operating SystemAn operating system unifying data, workflows, and execution across EVERSANA’s integrated ecosystem.
- Global Commercialization
  - European CommercializationAccelerate European commercialization with integrated launch, market access, engagement, and sustained growth services across markets.
  - Asia Pacific CommercializationAccelerate Asia Pacific commercialization with integrated launch, market access, engagement, and scalable growth across diverse and rapidly evolving markets.
- Therapeutic Depth
  - OncologyHarness deep oncology expertise and integrated support to accelerate development, launch and patient impact.
  - RareAdvance rare‑disease care with expert guidance, innovative technology and integrated support to speed patient access.
  - Cell & GeneLead cell & gene therapy success with a patient‑centered approach across the full lifecycle.
  - Neurology & CNSEnhance neurology and CNS therapies with specialized experience and connected services for complex patient needs.
  - Digital MedicinesEnable digital health innovation with services that personalize support, improve outcomes and meet value‑based care demands.
Our Services
- Distribution & Channel Management
  - Global Channel Management & 3PLOptimize global distribution with lean, tech‑driven 3PL solutions enabling fast, accurate and compliant delivery.
  - e-CommerceEnable direct‑to‑provider sales with a flexible e‑commerce model offering direct access, real‑time visibility and operational efficiency.
- Field Deployment
  - Field Deployment SolutionsStrengthen commercial impact with strategic solutions that drive access, affordability and targeted stakeholder engagement.
  - Medical DeploymentSupport product success with agile medical teams improving scientific conversations and maximizing strategic impact.
  - Learning & Performance ServicesEmpower teams with tailored learning solutions combining clinical insight, market access knowledge and selling skills.
- Patient Services
  - Access & HubEmpower patients with streamlined access solutions that simplify onboarding and accelerate the path to therapy.
  - Adherence SolutionsImprove adherence with tailored solutions that blend advanced technology, education and human support.
  - Affordability, Co-Pay & PAPStrengthen access through affordability programs designed to ease financial burdens and streamline coverage pathways.
  - Specialty PharmacyDeliver integrated clinical support, seamless access, coordinated care and precise delivery for complex therapies.
  - In-Home Nursing & Clinical SupportProvide safe, coordinated in‑home clinical care that supports ongoing treatment and complex therapies.
  - Clinical Trial ProgramsElevate trial performance through connected solutions that improve access, simplify participation and support retention.
- Market Access & Value
  - Market Access StrategiesPower your brand with integrated strategies built to define value, guide pricing and strengthen coverage.
  - Market Shaping Activation ModelDevelop market need for the therapy and build brand awareness across stakeholders.
  - Market Access & ReimbursementBreak down the complexity and navigate today’s shifts in healthcare.
  - Pricing & Revenue ManagementOptimize your revenue with solutions that improve pricing accuracy, reduce leakage and support regulatory compliance.
  - HEOR, Value & EvidenceStrengthen product value with evidence‑based insights and real‑world data that guide strategy and support decisions.
- Marketing
  - Patient, Payer & Provider MarketingDrive breakthrough results with insight‑led marketing powered by creativity, advanced tech and global expertise.
  - Digital Transformation & InnovationFuture‑proof your brand with AI‑enabled innovation and advanced tech solutions built for smarter execution.
- Medical Affairs
  - Medical Affairs StrategyAdvance decision‑making with evidence‑led expertise focused on improving care pathways and health outcomes.
  - Commercial ComplianceTransform compliance into a strategic advantage with integrated solutions that enhance quality and safety.
  - Medical InformationSupport launches and global growth with integrated, scalable solutions designed for evolving healthcare needs.
  - PharmacovigilanceLeverage GenAI and real‑time insights to elevate safety performance and enable faster, informed decisions.
  - Quality Assurance / Quality Management SystemsEnsure compliance and reduce risk with lifecycle‑wide quality solutions built for global readiness.
  - Regulatory Medical AffairsStrengthen product success with tailored strategies that support global clearance and guide development milestones.
- Strategy & Consulting
  - Management ConsultingNavigate healthcare complexity with expert insights, analytics and strategy that drive sustainable growth.
  - Regulatory ConsultingProvide customized solutions that accelerates approvals and supports every stage of development.
Our Products
- AI Enabled Marketing
  - OmnichannelUnify data, services, and activation into a single omnichannel model purpose-built for life sciences commercialization.
  - AI Agency PlatformProven AI platform, in partnership with Google, where you control data, outputs, and commercial roadmap.
  - Medical & Legal ReviewsStreamline medical and legal reviews with compliant, faster workflows purpose-built for life sciences teams globally.
- Compliance Operations
  - Literature Monitoring & Aggregate AuthoringLeverage integrated literature monitoring and aggregate authoring powered by connected data and scientific services.
  - Donor Eligibility SystemEnsure compliant donor eligibility with an integrated software that combines data, workflows, and life sciences expertise.
- Pricing & Market Access Products
  - Price & Access DataActivate NAVLIN price and access data through an integrated platform connecting insights, analytics, and decisions.
  - Research & InsightsMake smarter portfolio decisions with real-time visibility. The only digital platform and policy tracker that unifies all your market access insights.
  - Price & Access SoftwareDrive successful pricing governance decisions across global markets.
  - Revenue ManagementIntegrate your gross-to-net into the commercialization ecosystem.
- Data & Analytics
  - Commercial AnalyticsOptimize commercial performance with integrated analytics connecting data, insights, and activation.
  - Integrated Patient AnalyticsUnify patient data to reveal insights, personalize engagement, and improve outcomes.
  - Commercial Intelligence 360Unified intelligence platform designed to bring clarity, speed, and scalability to commercialization.
  - Patient Relationship AccessBuild trusted patient relationships by integrating access, engagement, and support across the ecosystem.
  - ACTICS eAccessState-of-the-art simplified benefits verification to accelerate reimbursement and access.
  - RWE & HEORDeliver robust real-world evidence and insights that demonstrate value, strengthen access, and inform decisions.
Our Insights

Content Library

Filter By:

Articles

The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost–effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective

Journal/Conference:: JCER
Author(s):: Osama O Zaidat, Xinguang Yang, Waleed Brinjikji, Emilie Kottenmeier, Hendramoorthy Maheswaran, Thibaut Galvain, Patrick A Brouwer, Mahmood Mirza, and Tommy Andersson
Publication Date:: 2025
Condition:: Stroke

Read More

A U.S. payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease

Journal/Conference:: JME
Author(s):: Stacey Priest, Alicyia Walczyk Mooradally, Erika Szabo, and Arturo Cabra
Publication Date:: 2025
Topic/Therapeutic Area:: Cardiovascular

Read More

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer

Journal/Conference:: The Oncologist
Author(s):: Elena Castro, Rhett Figliuzzi, Sarah Walsh, Samantha Craigie, Jonathan Nazari, Alexander Niyazov, Imtiaz A Samjoo
Publication Date:: 2025
Condition:: Oncology

Read More

Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review

Journal/Conference:: Frontiers in Oncology
Author(s):: Nadia Harbeck, Adam Brufsky, Chloe Grace Rose, Beata Korytowsky, Connie Chen, Krista Tantakou, Endri Jazexhi, Do Hoang Vien Nguyen, Meaghan Bartlett, Imtiaz A. Samjoo, Timothy Pluard
Publication Date:: 2025
Topic/Therapeutic Area:: Breast Cancer

Read More

Pitch Perfect: Strategic Guidance for Biotech Phase II Asset Acquisition

Posted on May 8, 20255/8/25

Read More

Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence

Journal/Conference:: Lung Cancer
Author(s):: Ernest Nadal 1, Nada Rifi 2, Sarah Kane 3, Sokhna Mbacke 3, Lindsey Starkman 3, Beatrice Suero 3, Hannah Le 2, Imtiaz A Samjoo
Publication Date:: 2024
Condition:: Cancer

Read More

The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost–effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective

Journal/Conference:: JCER
Author(s):: Osama O Zaidat, Xinguang Yang, Waleed Brinjikji, Emilie Kottenmeier, Hendramoorthy Maheswaran, Thibaut Galvain, Patrick A Brouwer, Mahmood Mirza, and Tommy Andersson
Publication Date:: 2024
Condition:: Stroke

Read More

A U.S. payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease

Journal/Conference:: JME
Author(s):: Stacey Priest, Alicyia Walczyk Mooradally, Erika Szabo, and Arturo Cabra
Publication Date:: 2024

Read More

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer

Journal/Conference:: The Oncologist
Author(s):: Elena Castro, Rhett Figliuzzi, Sarah Walsh, Samantha Craigie, Jonathan Nazari, Alexander Niyazov, Imtiaz A Samjoo
Publication Date:: 2024
Condition:: Cancer

Read More

Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons

Journal/Conference:: Therapeutic Advances in Neurological Disorders
Author(s):: Nicholas Riley, Christopher Drudge, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van der Walt, Erin O Y Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A Samjoo
Publication Date:: 2024
Condition:: Multiple Sclerosis

Read More